AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
75 hedge funds and large institutions have $25.5M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $31.8M → $25.5M (-$6.31M)
83% less call options, than puts
Call options by funds: $64K | Put options by funds: $384K
Holders
75
Holding in Top 10
1
Calls
$64K
Puts
$384K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$206K | |
| 3 | +$132K | |
| 4 |
VF
Virtu Financial
New York
|
+$128K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$77.7K |
Top Sellers
| 1 | -$104K | |
| 2 | -$89K | |
| 3 | -$60K | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$47K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$37.8K |